Healio

Polygenic component associated with HCM risk, offering prediction tool

Please provide your email address to receive an email when new articles are posted on . Rare and common genetic variants contribute substantially to susceptibility to hypertrophic cardiomyopathy in ...
Healthline

Testing for Hypertrophic Cardiomyopathy: Who Should Get It and How It Works

Hypertrophic cardiomyopathy (HCM) is a genetic heart disease that causes thickening of the walls of the heart’s left ventricle. This can make it more difficult for the heart to pump blood throughout ...
Healthline

Ask the Expert: How Does Genetic Testing Work for Hypertrophic Cardiomyopathy?

Hypertrophic cardiomyopathy (HCM) is a genetic heart condition that makes it hard for the heart to pump blood. Genetic testing is often recommended for family members of people with HCM. In this ...
Nasdaq

Cytokinetics Announces Launch of EARTH-HCM, a Public Health Education Tool for the Hypertrophic Cardiomyopathy Community

SOUTH SAN FRANCISCO, Calif., March 20, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced the launch of EARTH-HCM (Epidemiology, Awareness, Real-world Treatment and ...
Nasdaq

Cytokinetics Launches EARTH-HCM: An Interactive Tool for Understanding Hypertrophic Cardiomyopathy and Improving Access to Care

Cytokinetics has launched EARTH-HCM, an interactive online tool aimed at improving awareness and understanding of hypertrophic cardiomyopathy (HCM) in the U.S. Developed with input from prominent ...